EyePoint, Inc. (EYPT) vs Century Therapeutics, Inc. (IPSC)
EyePoint, Inc. and Century Therapeutics, Inc. are both Biotechnology companies. EyePoint, Inc. and Century Therapeutics, Inc. are of similar size ($324.2M and $306.0M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −94.6%. Century Therapeutics, Inc. has the higher net margin (0.00% vs −10,998.7%) and the lower return on invested capital (−64.9% vs 0.00%). Across the 16 metrics below, Century Therapeutics, Inc. leads on 14 and EyePoint, Inc. on 2.
Valuation
Profitability
| Metric | EYPT | IPSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.75% | 100.00% | 65.16% |
| Operating margin | (11,369.30%) | 0.00% | 0.00% |
| Net margin | (10,998.67%) | 0.00% | 0.00% |
| Free cash flow margin | (9,724.68%) | 0.00% | 0.00% |
| Return on equity | (148.70%) | (49.65%) | (57.72%) |
| Return on assets | (115.86%) | (38.41%) | (49.22%) |
| Return on invested capital | 0.00% | (64.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack